Alzheimer; News from the web:
And here is how. Read the article in our link for today that gives you 20 things to know to help you improve the brainhealth.
Read all about it HERE
Alzheimer; News from the web:
And here is how. Read the article in our link for today that gives you 20 things to know to help you improve the brainhealth.
Read all about it HERE
Alzheimer; News from the web:
Great Article by Yahoo style where they not only give 11 ways to prevent Alzheimer’s but also refer to the appropriate research that has come up with this way to avoid Alzheimer’s.
In short: Get sleep, get moving, eat mediterranean, be social, don’t (almost) drink, loose weight, learn new things, wear helmet and belts, get balanced, manage blood pressure, quit smoking.
Don’t just read this summery, go for the full article and take some great actions today!
Read all about it HERE
Alzheimer; News from the web:
Feelings of apprehension and fear are often observed in those suffering mild cognitive impairment (MCI), and previous research has suggested that anxiety could be an early indicator for Alzheimer’s disease, which often follows MCI. Now a new study has found an association between anxiety and an increased rate of progression from MCI to Alzheimer’s disease.
https://newatlas.com/
Read all about it HERE
Alzheimer; News from the web:
A company has started selling the first blood test to help diagnose Alzheimer’s disease, a leap for the field that could make it much easier for people to learn whether they have dementia. It also raises concern about the accuracy and impact of such life-altering news.
It has however not been approved by the FDA
Read all about it HERE
Alzheimer; News from the web:
Swiss biopharma AC Immune has made targeting Alzheimer’s disease, the leading form of dementia, a top priority. The company’s numerous candidates and platforms target several different proteins and pathways thought to have a central role in Alzheimer’s pathology. 2020 has brought mixed news for AC Immune. In July, the company announced that their candidate tau vaccine, ACI-35.030, had shown “encouraging” safety data at a lower dose and was to be progressed to a higher-dose group. However, September brought the disappointing news that their anti-tau antibody, semorinemab, did not meet its primary efficacy endpoints in a Phase 2 trial. To discuss AC Immune’s work, Technology Networks spoke to CEO Prof. Andrea Pfeifer.
https://www.technologynetworks.com/
Read all about it HERE
Alzheimer; News from the web:
Preparing for the holidays can be a sweet time together. But part of managing expectations involves staying focused on the task rather than the outcome. Mix batter, decorate cookies, open holiday cards or make simple decorations.
Read all about it HERE